Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$7.55 - $11.25 $3,020 - $4,500
-400 Reduced 0.42%
93,836 $789,000
Q2 2022

Jul 19, 2022

SELL
$6.8 - $14.23 $34,000 - $71,150
-5,000 Reduced 5.04%
94,236 $713,000
Q1 2022

May 12, 2022

BUY
$13.42 - $23.38 $65,771 - $114,585
4,901 Added 5.2%
99,236 $1.37 Million
Q4 2021

Feb 07, 2022

SELL
$12.78 - $23.74 $1,584 - $2,943
-124 Reduced 0.13%
94,335 $2.24 Million
Q3 2021

Nov 15, 2021

SELL
$11.73 - $16.08 $117 - $160
-10 Reduced 0.01%
94,459 $1.25 Million
Q2 2021

Aug 16, 2021

SELL
$12.85 - $16.2 $29,143 - $36,741
-2,268 Reduced 2.34%
94,469 $1.46 Million
Q1 2021

Apr 30, 2021

BUY
$13.84 - $17.8 $69,200 - $89,000
5,000 Added 5.45%
96,737 $1.4 Million
Q4 2020

Feb 05, 2021

SELL
$12.4 - $17.6 $101,518 - $144,091
-8,187 Reduced 8.19%
91,737 $1.39 Million
Q2 2020

Aug 14, 2020

BUY
$11.79 - $15.97 $12,662 - $17,151
1,074 Added 1.09%
99,924 $1.25 Million
Q1 2020

May 15, 2020

BUY
$9.31 - $21.24 $739,651 - $1.69 Million
79,447 Added 409.46%
98,850 $1.33 Million
Q4 2019

Feb 13, 2020

BUY
$13.91 - $21.48 $269,895 - $416,776
19,403 New
19,403 $388,000

Others Institutions Holding MGTX

About MeiraGTx Holdings plc


  • Ticker MGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,010,700
  • Market Cap $292M
  • Description
  • MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...
More about MGTX
Track This Portfolio

Track Claraphi Advisory Network, LLC Portfolio

Follow Claraphi Advisory Network, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Claraphi Advisory Network, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Claraphi Advisory Network, LLC with notifications on news.